Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 69401-69450 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05966623
Assessing the Impact of Vidéo Remote Sign Language Interpreting in Healthcare
NAEnrolling by invitation
183 participants
Started: Aug 24, 2023 · Completed: Jul 14, 2024
1 condition4 sponsors2 locations
NCT06375213
Investigating Neurocognitive Disorders Epidemiology
N/ARecruiting
990 participants
Started: Aug 24, 2023 · Completed: Aug 24, 2035
3 conditions2 sponsors1 location
NCT06532643
Safety and Efficacy of Anti-CD20/CD30 CAR-T Cells in Subjects with Relapsed/Refractory Lymphoma
EARLY_PHASE1Recruiting
9 participants
Started: Aug 24, 2023 · Completed: Sep 1, 2026
1 condition1 sponsor1 location
NCT06302595
MRI Guided Prostate Biopsy
NARecruiting
15 participants
Started: Aug 24, 2023 · Completed: Aug 31, 2024
1 condition3 sponsors1 location
NCT05971082
Risk Factors for Advanced Fibrosis Among FLD Patients
N/AEnrolling by invitation
1,000 participants
Started: Aug 24, 2023 · Completed: Dec 31, 2025
3 conditions2 sponsors1 location
NCT06033248
Using Urine Samples to Identify Lung Cancer
N/ARecruiting
210 participants
Started: Aug 24, 2023 · Completed: Aug 31, 2026
1 condition2 sponsors7 locations
NCT06012136
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Single Suspension Injection of Investigational Capsid Inhibitors Compared to Placebo in Healthy Adults
PHASE1Active, not recruiting
85 participants
Started: Aug 24, 2023 · Completed: Jun 9, 2026
1 condition1 sponsor2 locations
NCT05929235
A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma
PHASE1Recruiting
75 participants
Started: Aug 24, 2023 · Completed: Jan 30, 2027
4 conditions1 sponsor12 locations
NCT06065514
The Role of Inflammation in Myocardial Infarction
N/ARecruiting
120 participants
Started: Aug 24, 2023 · Completed: May 30, 2025
1 condition3 sponsors4 locations
NCT05974449
Lactobacillus Vaginalis Capsules for Treatment of Vulvovaginal Atrophy in Young Breast Cancer Patients
PHASE2Recruiting
60 participants
Started: Aug 24, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05962385
State Dependence of Prefrontal Transcranial Magnetic Stimulation
PHASE4Active, not recruiting
35 participants
Started: Aug 24, 2023 · Completed: Nov 1, 2025
1 condition1 sponsor1 location
NCT06423261
Safety, Tolerability, Pharmacokinetics and Immunogenicity Study of GB002 Recombinant Peptide Inhalation Solution in Healthy Subjects
PHASE1Active, not recruiting
100 participants
Started: Aug 24, 2023 · Completed: Jul 29, 2026
1 condition1 sponsor1 location
NCT06603402
Low-Dose Involved-Field Radiotherapy Plus Immunochemotherapy for ESCC
PHASE2Recruiting
41 participants
Started: Aug 24, 2023 · Completed: Sep 1, 2025
2 conditions1 sponsor1 location
NCT06422650
Effect of Nigella Sativa in Atorvastatin Treated Hyperlipidaemia
PHASE2Recruiting
84 participants
Started: Aug 24, 2023 · Completed: Aug 31, 2024
1 condition1 sponsor1 location
NCT06526741
ASF Alport Patient Registry
N/ARecruiting
2,500 participants
Started: Aug 24, 2023 · Completed: Aug 23, 2048
3 conditions2 sponsors1 location
NCT05814146
Trial of Variable Dialysate Bicarbonate
NARecruiting
141 participants
Started: Aug 24, 2023 · Completed: Oct 1, 2026
5 conditions1 sponsor1 location
NCT06014229
Cryoablation of Benign Thyroid Nodules: a Pilot Study
NAActive, not recruiting
10 participants
Started: Aug 24, 2023 · Completed: Nov 1, 2025
1 condition1 sponsor1 location
NCT05783570
To Evaluate the Safety, Tolerability and Preliminary Efficacy of EU307
PHASE1Recruiting
12 participants
Started: Aug 24, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor4 locations
NCT05842057
Human Amnion Membrane Allograft and Early Return of Erectile Function After Radical Prostatectomy
PHASE2Active, not recruiting
118 participants
Started: Aug 24, 2023 · Completed: Aug 31, 2028
2 conditions2 sponsors1 location
NCT05620719
Multisite Advancement of Research on Chronic Posttraumatic Headache
NARecruiting
525 participants
Started: Aug 24, 2023 · Completed: Aug 31, 2026
1 condition11 sponsors8 locations
NCT06440746
Efficacy and Safety of Olokizumab in Patients With Progressive Fibrosing Interstitial Lung Diseases
PHASE2/PHASE3Recruiting
138 participants
Started: Aug 23, 2023 · Completed: Dec 25, 2028
1 condition5 sponsors33 locations
NCT06014723
Balloon angiopLasty for Intracranial Atherosclerotic Minor Stroke/TIA
N/ARecruiting
416 participants
Started: Aug 23, 2023 · Completed: Dec 1, 2026
1 condition2 sponsors1 location
NCT05587218
Recognition of Second Language Spoken Words, Signs, and Characters Via Perception and Production in Adults
NANot yet recruiting
120 participants
Started: Aug 23, 2023 · Completed: May 8, 2026
1 condition2 sponsors1 location
NCT05989906
Feasibility of a Sprint Interval Training Program During Inpatient Spinal Cord Injury Rehabilitation
NAEnrolling by invitation
32 participants
Started: Aug 23, 2023 · Completed: Aug 1, 2025
1 condition2 sponsors1 location
NCT05841472
Anti-PD-1 Antibody Therapies of Camrelizumab in Combination With Pemetrexed and Carboplatin as First-line Treatment in Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
PHASE2Recruiting
60 participants
Started: Aug 23, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor8 locations
NCT06061354
Teriparatide on Maxillary Sinus Floor Osseointegration
PHASE4Recruiting
42 participants
Started: Aug 23, 2023 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT06364878
Non-invasive Diagnostics of Microbial Keratitis
N/ARecruiting
125 participants
Started: Aug 23, 2023 · Completed: Apr 8, 2028
1 condition1 sponsor1 location
NCT05677100
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
NARecruiting
295 participants
Started: Aug 23, 2023 · Completed: Jul 31, 2026
8 conditions1 sponsor46 locations
NCT05971810
Perioperative Oral Decontamination and ImmunoNuTrition (POINT) in Elderly
NARecruiting
592 participants
Started: Aug 23, 2023 · Completed: Sep 1, 2025
2 conditions7 sponsors2 locations
NCT05868525
Stroke Rate in Patients With Blunt Cerebrovascular Injury (BCVI) Treated With Oral Acetylsalicylic Acid (ASA) 81 mg Versus ASA 325 mg (BASA).
PHASE4Recruiting
98 participants
Started: Aug 23, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05094362
Operant Conditioning of Spinal Reflexes Training System--Reflex Operant Down Conditioning
NARecruiting
25 participants
Started: Aug 23, 2023 · Completed: Dec 31, 2026
4 conditions2 sponsors2 locations
NCT05983705
The Effect and Experience of the Parental Program AFFEKT
NARecruiting
200 participants
Started: Aug 23, 2023 · Completed: Dec 30, 2025
5 conditions4 sponsors1 location
NCT06020677
Latinx Children and Surgery
NARecruiting
120 participants
Started: Aug 23, 2023 · Completed: Aug 31, 2027
2 conditions2 sponsors1 location
NCT06714721
Magnetic Stimulation of Diaphragm in Chronic Obstructive Pulmonary Disease
NARecruiting
66 participants
Started: Aug 23, 2023 · Completed: Dec 4, 2025
1 condition1 sponsor1 location
NCT05764252
A Prospective Diagnostic Belief Updating Study to verIfy the Utility of BioEP in First Seizure Clinics.
N/AActive, not recruiting
88 participants
Started: Aug 23, 2023 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05594225
Tele-Rehabilitation to Improve Mild Traumatic Brain Injury Recovery and Reduce Subsequent Injury Risk
PHASE1Active, not recruiting
88 participants
Started: Aug 23, 2023 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT05925608
Clinical Trial of Human Allogenic Culture-expanded Bone Marrow-derived Mesenchymal Stem Cells
PHASE1/PHASE2Enrolling by invitation
39 participants
Started: Aug 23, 2023 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT06035224
A Study of Cadonilimab(AK104) Plus Lenvatinib in Previous Immunotherapy Treated Advanced/Metastatic Clear Cell Renal Cell Carcinoma
PHASE2Recruiting
28 participants
Started: Aug 23, 2023 · Completed: Oct 31, 2026
1 condition3 sponsors1 location
NCT05907031
pBFS-guided cTBS Over the Inferior Frontal Gyrus for Aphasia After Ischemic Stroke
NARecruiting
30 participants
Started: Aug 23, 2023 · Completed: Dec 30, 2025
2 conditions2 sponsors1 location
NCT05957445
pBFS-guided Multi-target cTBS for Aphasia After Stroke
NARecruiting
60 participants
Started: Aug 23, 2023 · Completed: Oct 1, 2025
2 conditions1 sponsor3 locations
NCT05742685
Refinement and Adaption of Reinforcement Learning to Personalize Behavioral Messaging for Healthy Habits
NAEnrolling by invitation
60 participants
Started: Aug 23, 2023 · Completed: May 30, 2026
2 conditions3 sponsors1 location
NCT05903547
Skin Glue Cesarean Study
NAActive, not recruiting
200 participants
Started: Aug 23, 2023 · Completed: Oct 31, 2025
3 conditions1 sponsor1 location
NCT05715086
UPURS Trial for Patient-centered Management of Symptomatic Obstructing Stones
NARecruiting
100 participants
Started: Aug 23, 2023 · Completed: Jun 30, 2026
1 condition3 sponsors1 location
NCT06623318
IV Ensure in Patients Receiving OPAT
NARecruiting
90 participants
Started: Aug 23, 2023 · Completed: Nov 30, 2024
1 condition2 sponsors1 location
NCT06565572
Antisense Oligonucleotide Treatment for PCARP Disease Due to Mutation in FLVCR1
EARLY_PHASE1Enrolling by invitation
1 participants
Started: Aug 23, 2023 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT06016764
Use of MRI and CTBS for Catatonia in Autism
PHASE1Recruiting
40 participants
Started: Aug 23, 2023 · Completed: Aug 23, 2026
3 conditions2 sponsors1 location
NCT05978102
A Dose Escalation and Dose Expansion Clinical Study of STI-7349 in Subjects With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
183 participants
Started: Aug 23, 2023 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT06305195
Potential Correlation Between Heart Rate Variability With Cardiovascular Risk at Different Stages of Metabolic Syndrome
N/ARecruiting
155 participants
Started: Aug 23, 2023 · Completed: Oct 21, 2026
1 condition1 sponsor1 location
NCT05439200
Video Treatment for Amblyopia
NARecruiting
44 participants
Started: Aug 23, 2023 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT05609669
Continuous And Data-drivEN CarE (CADENCE) Pilot
NAActive, not recruiting
10 participants
Started: Aug 23, 2023 · Completed: Sep 30, 2025
2 conditions1 sponsor1 location